Hyoscine Injection and Lenvatinib Mesylate
Determining the interaction of Hyoscine Injection and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: scopolamine
Brand name: Transderm-Scop
Synonyms: Scopolamine transdermal, Scopolamine (Systemic)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyoscine Injection-Lenvima
- Hyoscine Injection-Lenvima (14 MG Daily Dose)
- Hyoscine Injection-Lenvima (18 MG Daily Dose)
- Hyoscine Injection-Lenvima (20 MG Daily Dose)
- Hyoscine Injection-Lenvima (24 MG Daily Dose)
- Hyoscine Injection-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Hyoscyamine
- Lenvatinib Mesylate-Hyoscyamine and phenyltoloxamine
- Lenvatinib Mesylate-Hyoscyamine Extended-Release Tablets
- Lenvatinib Mesylate-Hyoscyamine Injection
- Lenvatinib Mesylate-Hyoscyamine Liquid
- Lenvatinib Mesylate-Hyoscyamine Orally Disintegrating Tablets